London Daily

Focus on the big picture.
Wednesday, Sep 03, 2025

Covax signs agreement with Moderna for 500 million doses of anticovid vaccine

Covax signs agreement with Moderna for 500 million doses of anticovid vaccine

"We are excited to sign this new agreement with Moderna, which gives Covax participants access to another highly effective vaccine," said Seth Berkley.
The Covax program, which favors the equitable distribution of vaccines, signed an agreement with Moderna to acquire 500 million doses of its anticovid vaccine, the Vaccine Alliance (Gavi) announced on Monday.

"We are very pleased to sign this new agreement with Moderna, which gives Covax participants access to another highly effective vaccine," said Seth Berkley, Gavi's CEO, in a statement.

The first doses of this messenger RNA vaccine should be delivered in the fourth quarter of 2021, "with a total of 34 million available" this year and "up to 466 million doses in 2022, the note said.

The Moderna vaccine is generally given in two doses, although the new recommendations call for a single dose if the patient has recently had COVID.

The agreement also contains "options that eventually make it possible to obtain vaccine doses adapted to future variants," the Geneva-based organization said.

"Expanding and diversifying the portfolio has always been a key goal for Covax, and to remain flexible in the face of this ever-evolving pandemic - including the growing threat of new variants," Berkley said. This agreement with Moderna "is one more step in this direction," he said.

The World Health Organization (WHO) on Friday granted its emergency homologation to Moderna's vaccine, a prerequisite for it to be integrated into the Covax system, which it established together with Gavi, and Cepi (Coalition for Epidemic Preparedness Innovations).

The agreement is "an important step in our efforts to ensure that populations around the world have access to our COVID-19 vaccine," said Moderna chief Stéphane Bancel, acknowledging that "many countries have limited resources to access to vaccines".

In addition to Moderna, the WHO has already licensed the vaccine from Pfizer-BioNTech, the two AstraZeneca sera manufactured in India and South Korea, and the one from Johnson & Johnson.

So far, Covax, whose main supplier remains AstraZeneca, has distributed more than 49 million vaccines in 121 countries and territories.

The vaccine developed by Moderna, a pioneering startup in anticovid vaccines, has characteristics similar to that developed by Pfizer-BioNTech, with 94.1% efficacy.
Newsletter

Related Articles

0:00
0:00
Close
Google Avoids Break-Up in U.S. Antitrust Case as Stocks Rise
Couple celebrates 80th wedding anniversary at assisted living facility in Lancaster
Information Warfare in the Age of AI: How Language Models Become Targets and Tools
The White House on LinkedIn Has Changed Their Profile Picture to Donald Trump
"Insulted the Prophet Muhammad": Woman Burned Alive by Angry Mob in Niger State, Nigeria
Trump Responds to Death Rumors – Announces 'Missile City'
Court of Appeal Allows Asylum Seekers to Remain at Essex Hotel Amid Local Tax Boycott Threats
Germany in Turmoil: Ukrainian Teenage Girl Pushed to Death by Illegal Iraqi Migrant
United Krack down on human rights: Graham Linehan Arrested at Heathrow Over Three X Posts, Hospitalised, Released on Bail with Posting Ban
Asian and Middle Eastern Investors Avoid US Markets
Ray Dalio Warns of US Shift to Autocracy
Eurozone Inflation Rises to 2.1% in August
Russia and China Sign New Gas Pipeline Deal
China's Robotics Industry Fuels Export Surge
Suntory Chairman Resigns After Police Probe
Gold Price Hits New All-Time Record
Von der Leyen's Plane Hit by Suspected Russian GPS Interference in an Incident Believed to Be Caused by Russia or by Pro-Peace or by Anti-Corruption European Activists
UK Fintechs Explore Buying US Banks
Greece Suspends 5% of Schools as Birth Rate Drops
Apollo to Launch $5 Billion Sports Investment Vehicle
Bolsonaro Trial Nears Close Amid US-Brazil Tension
European Banks Push for Lower Cross-Border Barriers
Poland's Offshore Wind Sector Attracts Investors
Nvidia Reveals: Two Mystery Customers Account for About 40% of Revenue
Woody Allen: "I Would Be Happy to Direct Trump Again in a Film"
Pickles are the latest craze among Generation Z in the United States.
Deadline Day Delivers Record £125m Isak Move and Donnarumma to City
Nestlé Removes CEO Laurent Freixe Following Undisclosed Relationship with Subordinate
Giuliani Seriously Injured in Accident – Trump to Award Him the Presidential Medal of Freedom
EU is getting aggressive: Four AfD Candidates Die Unexpectedly Ahead of North Rhine-Westphalia Local Elections
Lula and Putin Hold Strategic BRICS Discussions Ahead of Trump–Putin Summit
WhatsApp is rolling out a feature that looks a lot like Telegram.
Investigations Reveal Rise in ‘Sex-for-Rent’ Listings Across Canada Exploiting Vulnerable Tenants
Chinese and Indian Leaders Pursue Amity Amid Global Shifts
European Union Plans for Ukraine Deployment
ECB Warns Against Inflation Complacency
Concerns Over North Cyprus Casino Development
Shipping Companies Look Beyond Chinese Finance
Rural Exodus Fueling European Wildfires
China Hosts Major Security Meeting
Chinese Police Successfully Recover Family's Savings from Livestream Purchases
Germany Marks a Decade Since Migrant Wave with Divisions, Success Stories, and Political Shifts
Liverpool Defeat Arsenal 1–0 with Szoboszlai Free-Kick to Stay Top of Premier League
Prince Harry and King Charles to Meet in First Reunion After 20 Months
Chinese Stock Market Rally Fueled by Domestic Investors
Israeli Airstrike in Yemen Kills Houthi Prime Minister
Ukrainian Nationalist Politician Andriy Parubiy Assassinated in Lviv
Corporate America Cuts Middle Management as Bosses Take On Triple the Workload
Parents Sue OpenAI After Teen’s Death, Alleging ChatGPT Encouraged Suicide
Amazon Faces Lawsuit Over 'Buy' Label on Digital Streaming Content
×